Gene Technologies — Enzo Therapeutics
Gene Technologies
Pioneering nucleic acid technologies translated from research tools to therapeutic platforms. Enzo’s foundational patents in nucleic acid labeling, modification, and detection power next-generation gene therapies and companion diagnostics.
From Research Pioneer to Therapeutic Innovator
Enzo Life Sciences was among the first companies to develop non-radioactive nucleic acid labeling and detection technologies — innovations that fundamentally transformed molecular biology. Today, this deep expertise in nucleic acid chemistry is being translated into therapeutic applications. Our proprietary modified nucleotides, delivery platforms, and diagnostic technologies address critical challenges in gene therapy development including stability, cellular uptake, target specificity, and patient monitoring.
Nucleic Acid Therapeutics
Proprietary modified nucleotides and labeling chemistries enabling enhanced stability, cellular uptake, and target specificity for antisense oligonucleotides (ASOs) and siRNA therapeutics. Enzo’s chemical modifications improve nuclease resistance and reduce immunogenicity, extending therapeutic duration and enabling lower dosing regimens.
Gene Delivery Systems
Novel delivery platforms leveraging Enzo’s nucleic acid modification expertise for improved gene therapy vector design and non-viral delivery approaches. Our technologies support both viral vector optimization (AAV, lentiviral) and lipid nanoparticle-based delivery systems with enhanced tissue targeting capabilities.
AMPIVIEW® Diagnostic Platform
RNA visualization technology with single-molecule sensitivity for therapeutic monitoring applications. AMPIVIEW enables real-time detection and quantification of gene expression at the individual cell level, providing a powerful companion diagnostic platform for gene therapy programs and patient stratification.
SENTINEL® Molecular Beacons
Proprietary molecular beacon technology for real-time monitoring of nucleic acid therapeutics in cellular and tissue settings. SENTINEL probes provide critical pharmacokinetic and pharmacodynamic data for gene therapy development, enabling researchers to track therapeutic nucleic acid biodistribution and activity in vivo.
Gene Technologies — By the Numbers
Advance Your Gene Therapy Program
Connect with our business development team to explore licensing, co-development, and technology transfer opportunities across our therapeutic platforms.